{
    "Trade/Device Name(s)": [
        "NoCoding1 Plus Blood Glucose Monitoring System",
        "NoCoding1 Blood Glucose Test Strips",
        "NoCoding1 Glucose Control Solutions"
    ],
    "Submitter Information": "i-SENS, Inc.",
    "510(k) Number": "K160742",
    "Predicate Device Reference 510(k) Number(s)": [
        "K083468",
        "K080923"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA",
        "JJX"
    ],
    "Summary Letter Date": "November 18, 2016",
    "Summary Letter Received Date": "November 29, 2016",
    "Submission Date": "December 12, 2016",
    "Regulation Number(s)": [
        "21 CFR 862.1345",
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Glucose test system",
        "Blood Glucose Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "NoCoding1 Plus Blood Glucose Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical biosensor",
        "Amperometric method"
    ],
    "Methodologies": [
        "Quantitative measurement",
        "Electrochemical detection"
    ],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strip",
        "Control Solution",
        "Lancing device",
        "Lancet"
    ],
    "Document Summary": "FDA 510(k) summary for NoCoding1 Plus Blood Glucose Monitoring System using electrochemical biosensor technology for home monitoring of glucose in fresh capillary whole blood.",
    "Indications for Use Summary": "For quantitative measurement of glucose in fresh capillary whole blood from the fingertip; for self-testing by people with diabetes at home to monitor effectiveness of diabetes control; not intended for neonates, diagnosis, or screening of diabetes.",
    "fda_folder": "Clinical Chemistry"
}